{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:25:15Z","timestamp":1767165915033,"version":"build-2238731810"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":247,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Contrast Media &amp; Molecular Imaging"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>In order to explore the function of inhibiting the immune effect, the relationship between programmed death receptor 1 (PD\u20101) carrelizumab in the treatment of hepatocellular carcinoma\u2010induced scleritis and T cell activation is investigated. A total of 120 patients with primary liver cancer treated in the department of oncology of our hospital from July 2020 to January 2022 are selected and treated with carrelizumab. According to the occurrence of PD\u20101 carrelizumab treatment, the patients are divided into the scleritis group and nonscleritis group. The levels of T cells, PD\u20101, PD\u2010L1 proteins, and serum inflammatory factors at different time points are compared. The experimental results show that the occurrence of scleritis after liver cancer treatment with PD\u20101 carrelizumab is closely associated with Treg cells, the percentage of Th17\u2009cells, the expression of PD\u20101, PD\u2010L1 proteins, and inflammatory factors. It is clearly evident that PD\u20101 carrelizumab can increase the risk of scleritis by affecting T cell activation.<\/jats:p>","DOI":"10.1155\/2022\/4853481","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T16:05:08Z","timestamp":1662393908000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Retracted] Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD\u20101 Carrelizumab"],"prefix":"10.1155","volume":"2022","author":[{"given":"Yazhen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaixi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changpeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninghan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5101-008X","authenticated-orcid":false,"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00277.2019"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-io-s1-s05"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00925-8"},{"key":"e_1_2_8_4_2","article-title":"Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)","volume":"35","author":"National Health Commission of Prc","year":"2022","journal-title":"Chin J Dis"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7291586"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000625"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30457-1"},{"key":"e_1_2_8_8_2","first-page":"1","article-title":"Human mesenchymal stemcell-derived exosomes accelerate wound healing of mice eczema","volume":"33","author":"Wang M.","year":"2020","journal-title":"Journal of Dermatological Treatment"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.731"},{"key":"e_1_2_8_10_2","first-page":"171","article-title":"Changes and significance of IL-6, IL-10, IL-17 and HMGB1 in bronchoalveolar lavage fluid in children with severe pneumonia","volume":"37","author":"Chen M.","year":"2017","journal-title":"Chinese Journal of Emergency Medicine"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24162880"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s185202"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.07.025"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-016-3099-5"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx622"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.0c01757"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.05.016"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101916"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103048"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4663"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2018.1437078"}],"updated-by":[{"DOI":"10.1155\/2023\/9781974","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"record-id":"46366"},{"DOI":"10.1155\/2023\/9781974","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000}}],"container-title":["Contrast Media &amp; Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmi\/2022\/4853481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmi\/2022\/4853481.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2022\/4853481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:08:35Z","timestamp":1721790515000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/4853481"}},"subtitle":[],"editor":[{"given":"Yuvaraja","family":"Teekaraman","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1155\/2022\/4853481"],"URL":"https:\/\/doi.org\/10.1155\/2022\/4853481","archive":["Portico"],"relation":{},"ISSN":["1555-4309","1555-4317"],"issn-type":[{"value":"1555-4309","type":"print"},{"value":"1555-4317","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2022-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"4853481"}}